Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Van Emmenis L, Ku S-, Gayvert K, Branch JR, Brady NJ, Basu S, et al. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer. Cancer Res Commun. 2023;3(8):1447-1459.

Lam H, Saoud C, Shi Q, Wong KS, Cibas ES, Rooper LM, et al. Degenerative atypia in benign thyroid nodules: a potential diagnostic pitfall on fine-needle aspiration. J Am Soc Cytopathol. 2023;12(5):341-350.

Mukhopadhyay C, Zhou P. Role(s) of G3BPs in Human Pathogenesis. J Pharmacol Exp Ther. 2023;387(1):100-110.

Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu JM, et al. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023;58(7):835-838.

Guahmich NL, Man L, Wang J, Arazi L, Kallinos E, Topper-Kroog A, et al. Human theca arises from ovarian stroma and is comprised of three discrete subtypes. Commun Biol. 2023;6(1):7.

Choi IY, Ling J, Zhang J, Helmenstine E, Walter W, Bergman R, et al. The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. Res Sq. 2023.

Geizhals S, Magro CM, Lipner SR. Accessory Tragus Resembling a Hair Follicle Nevus. Skinmed. 2023;21(1):37.

Callegari K, Dash S, Uchida H, Shingai Y, Liu C, Khodarkovskaya A, et al. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proc Natl Acad Sci U S A. 2023;120(16):e2205786120.

Bhattacharya U, Kamran M, Manai M, Cristofanilli M, Ince TA. Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide. Cancers (Basel). 2023;15(2).

Yang HS, Rhoads DD, Sepulveda J, Zang C, Chadburn A, Wang F. Building the Model. Arch Pathol Lab Med. 2023;147(7):826-836.